Midazolam Injection
Product Images NDC 0404-9913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 0404-9913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Formula2.jpg (Formula2)

Formula2.jpg (Formula2)
Midazolam Open-ring Form is a type of medication that is used as a sedative and anesthetic. It is commonly used before medical procedures, such as surgery, to help relax patients and reduce anxiety. Midazolam works by binding to specific receptors in the brain that produce a calming effect. The open-ring form of Midazolam refers to a structural change in the molecule that makes it more water soluble and easier to administer into the bloodstream. This form of the medication is commonly used in hospital settings and has been shown to be safe and effective when used appropriately under medical supervision.*
FDA Label Image

Image1.jpg (Image1)

FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
Possible description: This is a list of reported symptoms and their frequencies. Headache occurred in 1.5% of cases and there is a word that was not able to recognize, possibly related to eosinophilia or erythema. Pain was reported in 3.7% of cases. Ndura...ton, which is not a recognizable medical term, and redness each occurred at a frequency of 0.5%. Muscle stiffness was reported in 0.3% of cases. The context and source of this data are not provided, so it is difficult to infer more information.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
This appears to be a list of possible side effects of a medication, including hiccoughs, nausea, vomiting, coughing, oversedation, headache, and drowsiness. It also mentions local effects at the injection site, such as tenderness, pain, redness, induration, and phlebitis.*
FDA Label Image

Image4.jpg (Image4)

FDA Label Image

Image5.jpg (Image5)

FDA Label Image

Image6.jpg (Image6)

FDA Label Image

Image7.jpg (Image7)

Image7.jpg (Image7)
The text describes the various strengths and packaging sizes of midazolam hydrochloride in vials. The concentration of the drug is either 1 mg/mL or 5 mg/mL, and the vials come in sizes ranging from 1 mL to 10 mL. The NDC codes for each packaging size are also provided.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This is a product description for Midazolam Hydrochloride injection, for IM or IV use only, that contains benzyl alcohol. Each milliliter contains Midazolam Hydrochloride, equivalent to 1mg of Midazolam, sodium chloride, edetate disodium, and benzyl alcohol as a preservative. The pH is adjusted to 3.5-3.7 with sodium hydroxide and, if necessary, hydrochloric acid. The product should be kept out of children’s reach and stored at a temperature of 20°C to 27°C (68°F to 77°F). The item number is 24B0885 and the lot number is XXXXXOOXKX with an expiration date in mm-yy format. The product is packaged by Henry Schein, Inc. The GTIN number is (01)20000000000000C and SER number is (21)000000000000C. Additional information can be found in the product's prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.